Your metabolism and your mind
Why your mental health keeps coming back to your metabolism: The Studies
Mood and metabolism are wired together. Women with PCOS have three to six times the odds of moderate or severe depression and anxiety. This page isn't about our products. It's about a link that's well established in the research and almost never mentioned in the appointment.
Study 1 — Metabolic health shapes mood
The Stanford-Led Study
Stanford researchers followed 601 adults — none of whom had ever had depression or anxiety — for nine years. The ones whose blood showed early signs of insulin resistance were far more likely to develop depression later: one common marker carried an 89% higher risk, and newly developing prediabetes carried 2.7 times the risk. Mood isn't separate from metabolism (Watson et al., 2021).¹
Study Attributes
Where It Was Published
Led by researchers at Stanford School of Medicine and published in the American Journal of Psychiatry — one of the field's most established journals.
The Prediabetes Finding
People who newly developed prediabetes — blood sugar creeping above normal, but not yet diabetes — within the study's first two years had 2.66 times the risk of developing depression over the follow-up (95% CI 1.13–6.27).
What This Study Can and Can't Say
This was a cohort study: it followed people over time and measured risk. It shows that insulin resistance predicts who develops low mood — not that one causes the other, and no supplement was tested in it. It's the 'why metabolism matters' link, not a product claim.
Study 2 — The PCOS-specific study
The PCOS-Specific Study
Researchers pooled 30 studies — 6,908 women across 10 countries. Women with PCOS had about four times the odds of serious low-mood symptoms, and over six times the odds of serious anxiety. Matching women for BMI didn't change it (Cooney et al., 2017).⁴
Study Attributes
Where It Was Published
Published in Human Reproduction — one of the world's leading reproductive-medicine journals — by researchers at the University of Pennsylvania. No funding was used and no conflicts of interest were declared.
It Isn't Because of Your Weight
When women were matched for BMI, women with PCOS still had over 3× the odds of depressive symptoms (OR 3.25) and over 6× the odds of anxiety symptoms (OR 6.30). The authors note that age, obesity, hyperandrogenism and insulin resistance don't fully explain the association.
What This Study Can and Can't Say
All 30 included studies were cross-sectional — they show the two conditions occur together, not that one causes the other. And no supplement was tested in them.
The biggest numbers
MOOD × METABOLISM
4×
the odds of serious low-mood symptoms with PCOS — even matched for BMI*⁴
the odds of serious anxiety symptoms with PCOS*⁴
the depression risk after newly developing prediabetes*¹
higher depression risk with one insulin-resistance blood marker*¹
It Isn't Because of Your Weight
In the BMI-matched analysis, women with PCOS still had over 3× the odds of depressive symptoms and over 6× the odds of anxiety symptoms. Age, obesity, hyperandrogenism and insulin resistance don't fully explain the association — the link runs deeper than the scale.
What These Numbers Mean
Both studies measure association and risk, not cause and effect. The PCOS meta-analysis is cross-sectional — it shows the two occur together. The Stanford-led cohort shows insulin resistance predicts who develops low mood. Neither tested a supplement.
⁴ PCOS meta-analysis: Cooney et al., 2017, Human Reproduction · ¹ Stanford-led cohort: Watson et al., 2021, American Journal of Psychiatry. Full citations at the bottom of the page.
Study 3 — Inositol supports insulin & serotonin signalling
The Evidence
Inositol sits on both sides of the mood–metabolism link. On the metabolic side: fasting insulin roughly halved over six months on the 40:1 blend in a placebo-controlled trial (Benelli, 2016²), and insulin after meals improved within three months in another (Nordio, 2019³). And in the brain, inositol helps carry serotonin's signal inside brain cells — which is exactly why researchers started testing it for mood.*
The Numbers
Fasting Insulin, −47%
Fasting insulin — the insulin in your blood after an overnight fast — roughly halved over the six months (20.19 → 10.74 μU/mL). The placebo group didn't change.*
HOMA Index, −42%
HOMA is a standard score doctors use to estimate insulin resistance from a simple blood test — the same kind of marker the Stanford-led study used to predict mood risk. Lower is better. It fell 42% on average, and didn't budge on placebo.*
The Brain Mechanism
Serotonin is one of the brain's main mood messengers. When it docks onto a brain cell, inositol is part of the relay that passes the message inside. That's the mechanism — the trials below took it from theory to placebo-controlled testing.
Study 4 — Significant at four weeks
Study Background
28 people with low mood were randomly split: 13 took 12 g of inositol daily, 15 took a placebo, for four weeks — and nobody knew who had which. (Levine et al., 1995).†
Study Attributes
Placebo-Controlled
One group gets the real thing. The other gets a look-alike dummy — a placebo. Comparing the two shows what the compound actually does, beyond the effect of believing it works.
Double-Blind
Neither the participants nor the researchers knew who was taking what until the study ended. That keeps hope and bias from skewing the results.
Where It Was Published
This trial was published in the American Journal of Psychiatry — one of the field's most established journals. The authors themselves called for replication, and we'd rather show you that honesty than hide it.
Study 4 — The Results
INOSITOL VS PLACEBO
12 g
of inositol daily led to significantly greater mood improvement than placebo at four weeks, on the standard clinical scale*†
to a measurable difference in mood versus placebo on the standard Hamilton mood scale*†
changes in blood count, kidney, or liver function recorded during the trial†
The Hamilton Rating Scale
The Hamilton scale is the standard questionnaire clinicians use in research to score low mood. In this trial, improvement on it was significantly greater with inositol than with placebo at week four.
About the 12 g Dose
Mood research has used 12 g of inositol per day — three times a standard Bodology serving (4 g). We show the study as it was run. The 4 g dose is the one studied for metabolic outcomes.
†Study 1: Levine J, Barak Y, Gonzalves M, Szor H, Elizur A, Kofman O, Belmaker RH. Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry. 1995;152(5):792–794. DOI: 10.1176/ajp.152.5.792. Small trial; the authors called replication "crucial." Study population was patients in psychiatric care — this is independent research on inositol, not on Bodology, and not a claim about treating any condition.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Study 5 — The honest meta-analysis
Study Background
Researchers pooled every proper double-blind trial of inositol for mood and anxiety up to 2013 — eleven trials, 312 people. The straight answer: combined, the results didn't reach statistical proof. Slightly more people responded on inositol than placebo, and the strongest signal was in premenstrual mood symptoms — promising in specific groups, not yet proven overall. We'd rather tell you that than oversell it (Mukai et al., 2014).‡
Study Attributes
What a Meta-Analysis Is
A meta-analysis pools many separate trials into one answer, so no single study's quirks can skew the picture. This one pooled every double-blind randomized inositol mood trial to 2013.
What "Mixed" Means Here
Pooled across all trials, inositol's effect on mood didn't reach statistical proof. It showed marginally more responders than placebo (p = 0.06), with the strongest signal in premenstrual mood symptoms (p = 0.07). Early and promising in specific groups — not yet proven overall.
‡Study 2: Mukai T, Kishi T, Matsuda Y, Iwata N. A meta-analysis of inositol for depression and anxiety disorders. Hum Psychopharmacol. 2014;29(1):55–63. DOI: 10.1002/hup.2369. Trial doses in the pooled studies were higher than a standard Bodology serving. All studies cited are independent research on inositol, not on Bodology.
¹ Watson KT, Simard JF, Henderson VW, Nutkiewicz L, Lamers F, Nasca C, Rasgon N, Penninx BWJH. Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study. Am J Psychiatry. 2021;178(10):914–920. DOI: 10.1176/appi.ajp.2021.20101479. Observational cohort; shows prediction, not causation; no supplement was tested.
² Benelli E, et al. Int J Endocrinol. 2016;2016:3204083. DOI: 10.1155/2016/3204083.
³ Nordio M, Basciani S, Camajani E. Eur Rev Med Pharmacol Sci. 2019;23(12):5512–5521. DOI: 10.26355/eurrev_201906_18223.
⁴ Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32(5):1075–1091. DOI: 10.1093/humrep/dex044. All included studies were cross-sectional — they show the two conditions occur together, not that one causes the other. The authors note that age, obesity, hyperandrogenism and insulin resistance don't fully explain the association.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. If you're struggling with your mental health, please talk to your doctor — a supplement is not a substitute for care.
